We're delighted to share that the FDA has granted approval to Eli Lilly's Kisunla™ (donanemab-azbt) for early symptomatic Alzheimer's disease. This achievement is a testament to the hard work and dedication of everyone involved. Our collaboration with Eli Lilly on this groundbreaking treatment highlights a pivotal moment in Alzheimer's research and patient care. Let's continue making an impact! 🌟🧠 #AlzheimersResearch #HealthcareInnovation #ClinicalTrials
ClinCloud Clinical Trials
Research Services
Maitland, FL 1,798 followers
Mission Guided. People Driven.
About us
Clincloud, LLC was established in 2017. This company was founded on the premise that patient engagement in clinical research is waning. Jessica felt a strong need to bring a sense of community and purpose back into the research space. By leveraging her 7 years of experience in patient recruitment and retention, Jessica sought to build a bridge between the community and effective clinical trial enrollment. The ClinCloud team envisions this connecting space to eventually be a collaborative hub of patients and research sites, facilitating research education and trial enrollment in the “ClinCloud.” In an effort to achieve this vision, ClinCloud aims to tackle the industry-wide epidemic of screen failures in clinical trials through the development of targeted prescreening initiatives to yield high throughputs of randomized patients. Our core belief is that by increasing the specificity of patient selection, we can optimize current and future clinical trials.
- Website
-
http://www.clincloudresearch.com
External link for ClinCloud Clinical Trials
- Industry
- Research Services
- Company size
- 11-50 employees
- Headquarters
- Maitland, FL
- Type
- Privately Held
- Founded
- 2017
Locations
-
Primary
Get directions
1640 N. Maitland Ave
Suite 1000
Maitland, FL 32751, US
-
Get directions
7000 Spyglass Ct
130
Viera East, Florida 32940, US
Employees at ClinCloud Clinical Trials
Updates
-
Part 2: Treatment, Risks, and What’s on the Horizon for MASH In this segment, we dive into the current treatment options for MASH, the associated health risks, and what’s on the horizon. Understanding these aspects is vital for effective management and improving patient outcomes. #Healthcare 🏥 #MASH 🩺 #LiverHealth 🍏 #Research #Treatment #HealthRisks #ClinCloud
-
Learn about MASH! Part 1 MASH (Metabolic dysfunction-associated steatohepatitis) is liver inflammation linked to obesity, diabetes, and high cholesterol. Understanding MASH is essential for effective management of these conditions. Stay tuned for more insights. #Healthcare #MASH #LiverHealth
-
ClinCloud Clinical Trials reposted this
🌟 Exciting news in the fight against Alzheimer's! A Food and Drug Administration advisory panel has endorsed Eli Lilly's experimental drug Donanemab, which has shown promise in slowing the early stages of this devastating disease. We are happy to have collaborated with Eli Lilly on this groundbreaking project. This recognition is a significant milestone, and we are thrilled to be part of such a crucial step forward in Alzheimer's treatment. Let's continue to support advancements in Alzheimer's research and treatment, staying informed and involved. Together, we can push for progress and support innovative solutions in healthcare. #Alzheimers #HealthcareInnovation #clincloud #EliLilly #Donanemab
FDA panel makes the call on much-anticipated Alzheimer's drug donanemab
usatoday.com
-
🌟 Exciting news in the fight against Alzheimer's! A Food and Drug Administration advisory panel has endorsed Eli Lilly's experimental drug Donanemab, which has shown promise in slowing the early stages of this devastating disease. We are happy to have collaborated with Eli Lilly on this groundbreaking project. This recognition is a significant milestone, and we are thrilled to be part of such a crucial step forward in Alzheimer's treatment. Let's continue to support advancements in Alzheimer's research and treatment, staying informed and involved. Together, we can push for progress and support innovative solutions in healthcare. #Alzheimers #HealthcareInnovation #clincloud #EliLilly #Donanemab
FDA panel makes the call on much-anticipated Alzheimer's drug donanemab
usatoday.com
-
In Parts 3 and 4 of our Alzheimer's series, Rosemary Laird explores current treatments and future research efforts for combating Alzheimer's. 💜 #EndAlz
-
In Part 2 of our Alzheimer's series, Dr. Rosemary Laird delves into the essential components of an Alzheimer's diagnosis. 💜 #AlzheimersAwareness #EndAlz
-
Join Rosemary Laird, our geriatrician and principal investigator, as she shares vital insights on Alzheimer's. 💜 Part 1. #AlzheimersAwareness #EndAlz
-
Exciting advancements in dementia research! A novel test can now predict dementia up to 9 years before diagnosis, offering hope for earlier intervention and better outcomes. Discover more in this insightful article from the New York Post. #DementiaAwareness #AlzheimersResearch #HealthcareInnovation
Novel test can predict dementia up to 9 years before diagnosis: study
nypost.com
-
Join us in raising awareness this Alzheimer's Awareness Month at ClinCloud Viera! Connect with our committed team, dedicated to empowering and educating as we strive to make a difference. 💜 #EndAlz
-